Study: NCT04825223

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Multicomponent Meningococcal B Vaccine
Description: Pharmaceutical form:Liquid suspension for injection in a single vial Four liquid suspensions and one diluent (only for Stage 1) Route of administration: Intramuscular

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Multicomponent Meningococcal B Vaccine
Description: Pharmaceutical form:Liquid suspension for injection in a single vial Four liquid suspensions and one diluent (only for Stage 1) Route of administration: Intramuscular

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Meningococcal Group B Vaccine MenB
Description: Pharmaceutical form:Liquid suspension for injection in a pre-filled syringe Route of administration: Intramuscular

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Meningococcal Group B Vaccine MenB
Description: Pharmaceutical form:Liquid suspension for injection in a pre-filled syringe Route of administration: Intramuscular

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Meningococcal Group B Vaccine MenB
Description: Pharmaceutical form:Liquid suspension for injection in a pre-filled syringe Route of administration: Intramuscular

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Meningococcal Group B Vaccine MenB
Description: Pharmaceutical form:Liquid suspension for injection in a pre-filled syringe Route of administration: Intramuscular

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Meningococcal Group B Vaccine (recombinant deoxyribonucleic acid [rDNA], component, adsorbed)
Description: Pharmaceutical form:Liquid suspension for injection in a pre-filled syringe Route of administration: Intramuscular

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Meningococcal Group B Vaccine (recombinant deoxyribonucleic acid [rDNA], component, adsorbed)
Description: Pharmaceutical form:Liquid suspension for injection in a pre-filled syringe Route of administration: Intramuscular

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Meningococcal Group B Vaccine (recombinant deoxyribonucleic acid [rDNA], component, adsorbed)
Description: Pharmaceutical form:Liquid suspension for injection in a pre-filled syringe Route of administration: Intramuscular

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Meningococcal Group B Vaccine (recombinant deoxyribonucleic acid [rDNA], component, adsorbed)
Description: Pharmaceutical form:Liquid suspension for injection in a pre-filled syringe Route of administration: Intramuscular

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Pharmaceutical form:Liquid solution for injection in a vial Route of administration: Intramuscular

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Pharmaceutical form:Liquid solution for injection in a vial Route of administration: Intramuscular

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Pharmaceutical form:Liquid solution for injection in a vial Route of administration: Intramuscular

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Pharmaceutical form:Liquid solution for injection in a vial Route of administration: Intramuscular

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine MenACYW conjugate vaccine
Description: Pharmaceutical form:Liquid solution for injection in a vial Route of administration: Intramuscular

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine MenACYW conjugate vaccine
Description: Pharmaceutical form:Liquid solution for injection in a vial Route of administration: Intramuscular

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine MenACYW conjugate vaccine
Description: Pharmaceutical form:Liquid solution for injection in a vial Route of administration: Intramuscular

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine MenACYW conjugate vaccine
Description: Pharmaceutical form:Liquid solution for injection in a vial Route of administration: Intramuscular

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine MenACYW conjugate vaccine
Description: Pharmaceutical form:Liquid solution for injection in a vial Route of administration: Intramuscular